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illustrates the PRISMA flow chart of study selection process. The initial combined search identified 25,311 articles from 5 databases and 19 articles from other sources (manual searching and through references). The titles of the articles were reviewed, and duplicates were removed which resulted in 25,263 being excluded as they did not focus on oral conditions among palliative patients. The abstracts of the remaining 67 articles were read to ensure the relevance of the articles to our study. This resulted in 28 articles being excluded. Two reviewers (ZR and DR) then independently read the remaining 39 articles and coded them for inclusion or exclusion. Following the independent review, the two reviewers met to discuss preliminary findings and to reach a consensus on the studies to be included, and thirty studies were excluded. Thus, for the purpose of analysis, there were a total of nine articles.
Data extraction
In the data extraction process, the study details are extracted in Table 1 . This was done by two reviewers (ZR and DR). All reviewers discussed each article to reach consensus regarding the study details. The following information was extracted from each included study: author (s), year published, title, purpose, setting, origin of specimens, techniques, and microflora.
Assessment of study quality
The quality of the identified studies was assessed using Joanna Briggs Institute critical appraisal tool (a checklist for analytical cross-sectional studies) which consisted of eight questions focusing on the clarity of inclusion criteria, study subjects, setting, validity and reliability of the exposure and outcome measures, issues on confounding factors, and appropriateness of statistical analysis used. [9] Each question has a choice of "yes," "no," "unclear," or "not applicable" as an answer. Then, an overall appraisal was made whether to include or exclude each study, or to seek further information, with comments. Only the articles that were agreed by all involved researchers were included in this systematic review to inform the findings.
Data analysis
Extracted data from all included studies were analyzed using the Whittemore and Knafl principles of integrative review with four stages: data reduction, data display, data comparison, and conclusion drawing and verification. [10] At data reduction stage, all nine primary sources included in the integrative review were divided into a predetermined conceptual classification aligned with the aim of this review which is microbiological presence in the oral cavity of palliative patients and its identification techniques. Each primary source was reduced to a single page (available on request from authors). This helped us to systematically At Stage 2 -data display, the single-page data from the nine included studies are then extracted and displayed in Table 1 . This helped us to visualize the patterns and relationships between and within primary data sources.
At Stage 3 -data comparison, we used constant comparison as a method of an iterative process of examining data to identify themes that had similar patterns and relations.
Finally, at Stage 4 -conclusion and verification, we verified patterns using primary data and identified any similarities, differences, and any spurious findings. These were dealt with in order to ensure that valuable information was not lost. Five meetings were held in order to identify and reach a consensus on the final themes.
results

Characteristics of study
Overall, nine articles were found eligible and included in this review. The included study settings involved patients of advanced cancer conditions or palliative patients from five European, three Asian, and one American country. The total number of each study participants ranged from 54 to 390. The microbiological evidence of oral conditions among palliative patients of the nine eligible studies is summarized in Table 1 .
Common oral microorganisms present in palliative patients
Of nine studies, seven specifically reported Candida presence in the oral cavity of palliative patients. [3, [11] [12] [13] [14] [15] [16] Two studies reported the presence of yeast carriage. [17, 18] C. albicans was the predominant species with at least 50% of the total mycological infection reported in seven of nine studies [ Table 1 ]. Other species of Candida reported were Candida glabrata, Candida dubliniensis, Candida tropicalis, Candida parapsilosis, and Candida krusei.
Predisposing factors for oral microbial pathology among palliative patient
Two studies reported dentures, xerostomia, and oral hygiene as predisposing factors for oral microbial pathology among palliative patients. [11, 17] Another study reported antibiotic and corticosteroid usage as predisposing factors for Candida species infections. [15] Another prospective study considered clinical findings and laboratory findings to develop appropriate treatment strategies. [18] Association between oral symptoms and oral microbial flora Only three studies reported a significant association between the presence of oral symptoms and the oral microbial flora, Jayachandran et al. found a significant association between dry mouth symptom and presence of Candida species. [3] Davies reported that oral yeast carriage and denture wearing were significantly associated (P < 0.006). Similarly, there was an association between oral yeast carriage and low salivary flow rate (P < 0.009). [11] Finally, a significant association was reported between prior treatment with triazole and isolation of fluconazole-resistant C. albicans (P < 0.005), but this relationship was not observed in C. glabrata isolates (P = 0.4). [13] The other six studies reported only the mean and percentage of various Candida species.
Techniques used for identification of microbiological presence
Of the nine studies, eight studies used oral swabs to identify the microbiological presence except one, [13] where a germ tube test was used for presumptive identification of C. albicans.
In five studies, Sabouraud dextrose agar and/or CHROMagar were used for isolation of microbes, [3, 11, 12, 15, 17] one study used Trypticase agar slants, [13] another study used HiCrome Candida differential agar, [14] and two studies did not specify the type of agar used. [16, 18] Two studies adapted antifungal susceptibility test that used minimum inhibition concentration of various antifungal agents such as azoles, nystatin, and amphotericin against different isolates of Candida species. [12, 16] Another two studies performed Clinical and Laboratory Standards Institute-guided microbroth dilution method to detect antifungal susceptibility. [3, 14] Another study used the National Committee for Clinical Laboratory Standards guidelines to identify antifungal susceptibility. [13] disCussioN Our systematic review found Candida as the most common microflora in the oral cavity of palliative patients, with C. albicans being the predominant species. This finding is worrying because although C. albicans is often present as commensal in the oral cavity, their transition as an opportunistic pathogen is made possible when the host defense is compromised, [19] for example, patients undergoing chemotherapy and/or radiotherapy targeting carcinomas and sarcomas. [19] This is evident as oral candidiasis is common in head-and-neck cancer patients, [19] with 70%-75% Candida carriage in patients taking chemotherapy and/or radiotherapy. [20] A study reported that chemotherapy and/or radiotherapy causes mucositis and changes in saliva consistency. Xerostomia or thick saliva makes the oral environment conducive for fungal colonization. [21] Oral candidiasis is also a common side effect of cancer treatments which harm the body's mucous membranes and further weaken the immune system, making it more difficult for the body to fight off the Candida infection. [16, 22] Studies have suggested the use of antifungal medications during cancer treatment to prevent an infection. [16, 22] In palliative conditions, diverse form of antifungal medications, such as mouthwashes, gels, ointments, capsules, or given as an infusion, and can help to have an effect on a limited local region (topical), on the entire body (systemic) or with a combined effect. However, no evidence is available whether these antifungal medications can help reduce other oral candidiasis symptoms such as pain or difficulty swallowing.
There are various techniques available for the isolation of Candida within the oral cavity such as the use of smear, an imprint culture, collection of whole saliva, concentrated oral rinse, and mucosal biopsy, [23] and the majority of our included studies only used oral swabs for isolation. It is a relatively simple method of detecting growth of microflora, site specific, and can obtain semi-quantitative estimation of Candida, and this technique is difficult to standardize. [23] Since Candida is the resident microflora within the oral cavity, a more reliable and appropriate isolation methods are required to ascertain its presence along with their quantity.
CoNClusioN
To our knowledge, this study is the first systematic review taking into account the techniques to identify the oral microflora among palliative patients. It is hoped that the information generated from this review will lead to a better understanding of oral conditions among palliative patients in order to direct the treatment options and enhance the quality of care for these terminally ill patients. Future studies with multicenter approach may help to develop standardized clinical guidelines for oral care of palliative patients.
